STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Pursuant to chapter 4, § 9 of the Swedish Financial Instruments Trading Act (1991:980), the company is hereby reporting that as a result of new share issue conducted by NeuroVive Pharmaceutical AB (STO:NVP) (“NeuroVive”), as resolved by the Annual General Meeting (AGM) on 30 March 2015 and decided by the Board of Directors on 8 May 2015 with the authorization of the shareholders’ meeting, the number of shares and votes of NeuroVive registered with the Swedish Companies Registration Office have increased by 1,647,059. Accordingly, the total number of shares and votes in NeuroVive is 30,735,152.
Help employers find you! Check out all the jobs and post your resume.
